Lupus Clinical Trials in Phoenix

Showing 141-160 of 165 trials

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

NCT01146782

This is a prospective study of the Attune Sleep Apnea System for the treatment of obstructive sleep apnea. The objective of the study is to demonstrate safety and effectiveness of the Attune Sleep Apnea System to support FDA marketing clearance of the device.

Obstructive Sleep Apnea

ApniCure, Inc.367 participantsStarted Jun 2010

Phoenix, Arizona, United States • Burlingame, California, United States • Menlo Park, California, United States +3 more locations

COMPLETEDPhase 3< 1 mile

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

NCT00107848

The primary objective of the study is to evaluate the safety and tolerability of treatment with PROVIGIL in children and adolescents with excessive sleepiness (ES) associated with narcolepsy or OSAHS (obstructive sleep apnea/hypopnea), when administered for up to 12 months. Safety and tolerability will be evaluated throughout the study by means of adverse event information, clinical laboratory test results, vital signs measurements, and body weight and height measurements; quarterly physical examination findings; and 12 lead electrocardiograph (ECG) evaluations at the end of the study. In addition, the cognitive and behavioral effects of PROVIGIL will be assessed quarterly as measured by the Child Behavior Checklist for Ages 6-18 (CBCL/6-18), a brief psychiatric interview, and the Kaufman Brief Intelligence Test (KBIT 2).

NarcolepsySleep Apnea, Obstructive

Cephalon280 participantsStarted Oct 2004

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +58 more locations

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Lupus Trials in Other Cities

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Study of Epratuzumab in Systemic Lupus Erythematosus

Study of Epratuzumab in Systemic Lupus Erythematosus

Study of Epratuzumab in Systemic Lupus Erythematosus

Safety and Efficacy of Ramelteon in Healthy Subjects

A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.

Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor

Etanercept for the Treatment of Lupus Nephritis

Reiterative Development and Evaluation Study of OSA Therapy System

Other Conditions in Phoenix